Identification of pigment cell antigens defined by vitiligo antibodies
- PMID: 1370675
- DOI: 10.1111/1523-1747.ep12555773
Identification of pigment cell antigens defined by vitiligo antibodies
Abstract
Patients with vitiligo have circulating antibodies to pigment cells. To characterize this response further and to identify the antigens defined by vitiligo antibodies, sera of 23 patients with vitiligo and 22 patients with unrelated conditions were analyzed by immunoprecipitation and SDS-PAGE analysis of 125I-labeled cell antigens on pigment and control cells. Antibodies to pigment cell antigens were present in 18 (78%) of the patients with vitiligo but in only three (14%) of the control patients (p less than 0.05). The antibodies were directed to one or more antigens with molecular weight (MW) in kilodaltons (kD) of approximately 35, 40-45, 75, 90, or 150. The responses were most commonly directed to the 40-45-kD, 75-kD, and 90-kD antigens. Antibodies to these antigens were present in 74%, 57%, and 35% of vitiligo patients versus in 14%, 9%, and 0% of control individuals. The 35-kD and 90-kD antigens were preferentially expressed on human pigment cells, whereas the 40-45-, 75-, and 150-kD antigens were expressed on both pigment and control cells. These antigens were labeled by the lactoperoxidase technique, suggesting that they are cell surface antigens. These results confirm that antibodies to pigment cells are associated with vitiligo. These antibodies are directed to several cell surface antigens, some of which are preferentially expressed on pigment cells.
Similar articles
-
Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells.Arch Dermatol. 1995 Mar;131(3):314-8. Arch Dermatol. 1995. PMID: 7887661
-
Characterization of vitiligo antigens.Pigment Cell Res. 1995 Feb;8(1):53-9. doi: 10.1111/j.1600-0749.1995.tb00774.x. Pigment Cell Res. 1995. PMID: 7792255
-
Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.J Dermatol Sci. 1996 Feb;11(2):111-20. doi: 10.1016/0923-1811(95)00427-0. J Dermatol Sci. 1996. PMID: 8869031
-
Vitiligo and antibodies to melanocytes.Prog Clin Biol Res. 1988;256:195-206. Prog Clin Biol Res. 1988. PMID: 3285350 Review.
-
Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.Autoimmun Rev. 2007 Jan;6(3):138-42. doi: 10.1016/j.autrev.2006.09.010. Epub 2006 Oct 2. Autoimmun Rev. 2007. PMID: 17289548 Review.
Cited by
-
Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).Clin Exp Immunol. 1998 Dec;114(3):333-8. doi: 10.1046/j.1365-2249.1998.00746.x. Clin Exp Immunol. 1998. PMID: 9844040 Free PMC article.
-
Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.Drug Discov Today Dis Mech. 2008;5(2):e189-e199. doi: 10.1016/j.ddmec.2008.02.001. Drug Discov Today Dis Mech. 2008. PMID: 19578486 Free PMC article.
-
New treatment modalities for vitiligo: focus on topical immunomodulators.Drugs. 2005;65(4):447-59. doi: 10.2165/00003495-200565040-00002. Drugs. 2005. PMID: 15733009 Review.
-
Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.Open Access Maced J Med Sci. 2018 Jan 21;6(1):46-48. doi: 10.3889/oamjms.2018.042. eCollection 2018 Jan 25. Open Access Maced J Med Sci. 2018. PMID: 29483979 Free PMC article.
-
Stability in Vitiligo: Is there a Perfect Way to Predict it?J Cutan Aesthet Surg. 2013 Apr;6(2):75-82. doi: 10.4103/0974-2077.112667. J Cutan Aesthet Surg. 2013. PMID: 24023428 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical